机构：[1]Department of General Surgery,Xuanwu Hospital, Capital Medical University, Beijing, China外科系统普通外科首都医科大学宣武医院[2]Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China外科系统血管外科首都医科大学宣武医院
This study investigates whether medication therapy alone is as effective and safe as percutaneous revascularization (PR) in patients with atherosclerotic renal artery stenosis (ARAS).The Embase, PubMed, and Cochrane Library databases were searched from their inception to July 31, 2021, for randomized controlled trials (RCTs) reporting PR for ARAS. RevMan 5.3 was employed to analyze the retrieved articles.Eight studies with a total of 2,225 ARAS patients were included in this analysis, demonstrating that PR and medication therapy alone had a similar effect on both systolic [mean difference (MD)= 0.19, 95% CI: -1.64- 2.02] and diastolic blood pressure (MD= -0.44, 95% CI: -1.68-0.80). Meanwhile, there were no differences in all-cause mortality [Odds ratio (OR) = 0.89, 95% CI: 0.70-1.14], stroke (OR = 0.84, 95% CI: 0.55-1.31), congestive heart failure (OR = 0.89, 95% CI: 0.67-1.19), and perioperative complications (OR = 0.87, 95% CI: 0.68-1.12).Medication therapy alone is as effective and safe as PR.
第一作者机构：[1]Department of General Surgery,Xuanwu Hospital, Capital Medical University, Beijing, China
通讯作者：
推荐引用方式(GB/T 7714)：
Li Y,Cui W-H,Wang J,et al.Percutaneous revascularization for atherosclerotic renal artery stenosis: a meta-analysis[J].EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES.2022,26(19):7007-7014.doi:10.26355/eurrev_202210_29884.
APA：
Li Y,Cui W-H,Wang J,Chen X,Zhang C...&Luo T.(2022).Percutaneous revascularization for atherosclerotic renal artery stenosis: a meta-analysis.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,26,(19)
MLA：
Li Y,et al."Percutaneous revascularization for atherosclerotic renal artery stenosis: a meta-analysis".EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 26..19(2022):7007-7014
